Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Micron Shares Surge on Upgraded Outlook and Record Performance

Dieter Jaworski by Dieter Jaworski
January 3, 2026
in AI & Quantum Computing, Analysis, Nasdaq, Semiconductors, Tech & Software
0
Micron Stock
0
SHARES
29
VIEWS
Share on FacebookShare on Twitter

Micron Technology’s stock experienced a significant rally, climbing over 10% in a single session to establish a fresh 52-week peak at $315.42. This upward movement was catalyzed by a substantial price target revision from Bernstein, where analysts raised their projection from $270 to $330 per share. According to Bernstein’s Mark Li, the adjustment reflects sustained robust demand for High-Bandwidth Memory (HBM) used in artificial intelligence applications, coupled with favorable pricing trends in the DRAM market.

Strong Quarterly Results Underpin Confidence

The current market enthusiasm is firmly rooted in Micron’s exceptional financial report for its first fiscal quarter of 2026. The company posted revenue of $13.64 billion, a 57% year-over-year increase that handily surpassed the $12.62 billion consensus estimate. Adjusted earnings per share nearly tripled to $4.78, dramatically exceeding analyst forecasts of $3.77.

Key profitability metrics showed remarkable improvement. The gross margin expanded to approximately 57%, up from 25% previously. Furthermore, operating cash flow more than doubled, reaching $8.41 billion. CEO Sanjay Mehrotra highlighted that the total addressable market for HBM is now anticipated to hit $100 billion by 2028—two years ahead of prior expectations. This market was valued at roughly $35 billion in 2025.

Analyst Sentiment Turns Increasingly Bullish

Bernstein’s updated assessment joins a chorus of positive analyst commentary following Micron’s mid-December earnings release. Wolfe Research elevated its price target to $350. Bank of America upgraded the stock from “Neutral” to “Buy,” simultaneously raising its target from $250 to $300. Piper Sandler and Citigroup also issued upward revisions, with Citigroup establishing a new fair value estimate of $330.

Should investors sell immediately? Or is it worth buying Micron?

The consensus rating among 37 covering analysts remains a “Buy.” Recent target increases have pushed the average price target significantly higher from its previous level of $283. Trading activity intensified alongside the price surge, with volume hitting 41.9 million shares on Friday—about 62% above the three-month average.

Guidance Signals Continued Momentum

For the ongoing second fiscal quarter, Micron has provided an outlook that exceeds market expectations. The company forecasts revenue of $18.7 billion, representing sequential growth of 37%. It anticipates its gross margin will rise to 68%, with adjusted earnings per share climbing to $8.42.

Management noted that its entire HBM production capacity for calendar year 2026, including the next-generation HBM4, is already sold out. Bernstein’s Mark Li projects DRAM prices will increase between 20% and 25% in the second quarter. Micron’s own guidance suggests the company may possess even greater pricing power.

Investors are likely to focus on upcoming developments in HBM customer acquisitions and further DRAM market pricing trends ahead of the next quarterly report, expected in mid-March.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from February 8 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Micron: Buy or sell? Read more here...

Tags: Micron
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Next Post
Barrick Stock

Barrick Gold Shares Surge Following a Landmark Fiscal Performance

Bloom Energy Stock

Fuel Cell Stocks Surge as Bloom Energy Secures Major Financing

Solana Stock

Solana's Crossroads: Robust Fundamentals Meet Market Headwinds

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com